Traumagel: a novel hemostatic device for rapid, reliable hemorrhage control
Ended Purchase Order Awarded
- Contract number
- FA864926P0035
- Awardee
-
Cresilon, Inc. UEI RT8LEMLKJ6F7
- Awarding agency
-
Air Force Research Laboratory
Air Force Materiel Command, Department of Defense
- Obligated
- $74,694
Award facts
- Contract value 100% obligated
- $74,694.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Brooklyn, NY 11215, USA
Award details come from SAM.gov/FPDS.
About this award
The Air Force Research Laboratory awarded a purchase order to Cresilon, Inc. for $74,694.00 on July 22, 2026, for TraumaGel, a novel hemostatic device for rapid, reliable hemorrhage control. The order is set aside for Total Small Business and carries a firm fixed price structure. Work is performed in Brooklyn, New York, with an ultimate completion date of October 23, 2026.
Quick answers
Who was awarded contract FA864926P0035?
FA864926P0035 was awarded to Cresilon, Inc. by Air Force Research Laboratory (Air Force Materiel Command) on July 22, 2026.
How much is contract FA864926P0035 worth?
The government has obligated $74,694 on FA864926P0035.
Was contract FA864926P0035 competed?
The extent of competition for FA864926P0035 was full and open competition after exclusion of sources. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award